Sign In
Buy KPTI
$9.00
-0.230 (-2.49%)
At Close: Jun 03, 2026
In Africa, those who beat coronavirus continue to live under its cloud - Vanguard News
02:02pm, Thursday, 18'th Jun 2020
As coronavirus cases accelerate in Africa, those who recover from the virus find that their struggle is not over as denial of the disease and stigmatisation run deep across the continent. People who h
In Africa, those who beat the virus continue to live under its cloud - France 24
01:26pm, Thursday, 18'th Jun 2020
In Africa, those who beat the virus continue to live under its cloud
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bausch Health
Karyopharm Brain Cancer Trial, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:KPTI)
09:24am, Monday, 15'th Jun 2020
Karyopharm doses first patient in a phase 1/2 brain cancer trial. Dynavax completes enrolment for phase 1 clinical trial of Heplisav-B. BeyondSpring reports pos
Analysts Are Bullish on These Healthcare Stocks: Magenta Therapeutics (MGTA), Viela Bio (VIE) - Markets
01:55am, Monday, 15'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Magenta Therapeutics
Edited Transcript of KPTI earnings conference call or presentation 5-May-20 12:30pm GMT
07:58pm, Friday, 12'th Jun 2020
Q1 2020 Karyopharm Therapeutics Inc Earnings Call
Karyopharm Presents XPOVIO® (selinexor) and Eltanexor Data at the European Hematology Association 2020 Virtual Annual Meeting
11:00am, Friday, 12'th Jun 2020
NEWTON, Mass., June 12, 2020 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an innovation-driven pharmaceutical company, today announced that eight posters relating to XPOVIO®.
Govt To Invest In 52 Startups Providing Covid-19 Healthcare Solutions
02:28pm, Thursday, 11'th Jun 2020
Indian government, through its CAWACH initiative, has is looking to invest in 52 startups developing solutions to tackle Covid-19 pandemic.
Small Caps Build Steam And Biotechs Remain Well-Positioned
02:15pm, Wednesday, 10'th Jun 2020
Economic optimism has broadened the market rally. Small caps had lagged significantly and are now catching-up as they narrow the performance gap. The Federal Re
Karyopharm Starts Dosing in Selinexor Study for Glioblastoma
02:04pm, Wednesday, 10'th Jun 2020
Karyopharm (KPTI) commences a phase I/II study evaluating Xpovio (selinexor) in combination with standard-of-care therapy in patients with newly-diagnosed or recurrent glioblastoma.
Pedidos de seguro-desemprego somam 960.258 em maio, com alta de 53%
03:56pm, Tuesday, 09'th Jun 2020
Com a crise econ
Seguro-desemprego: país tem 960 mil pedidos em maio; total durante pandemia vai a 1,9 milhão
01:42pm, Tuesday, 09'th Jun 2020
Números foram divulgados nesta terça-feira pelo Ministério da Economia. Desde o início da pandemia do novo coronavírus, quase 2 milhões de pessoas pediram o seguro-desemprego.
Karyopharm Therapeutics Inc. (KPTI), an innovation-driven pharmaceutical company, today announced dosing of the first patient in a Phase 1/2 clinical study evaluating oral selinexor in combination wit
[Funding alert] PadUp mentee Ameliorate Biotech raises Rs 2 Cr in angel round
07:31am, Tuesday, 09'th Jun 2020
The Bengaluru-based startup has received funding from Friends of PadUp, Villgro USA, Vinners, LetsVenture, SINE IIT Bombay, and DERBI. Funds will be used to conclude clinical trials efficiently, and f
